Treatment of Malaria/Rational Drug Use 1  11/15/2005
The Fourth MIM Pan-African Malaria Conference, Yaoundé, Cameroon

View Webcast ( video ) ( transcript )

Chairs:

Theonest Mutabingwa, Ph.D., senior lecturer, London School of Hygiene & Tropical Medicine, principal researcher, National Institute of Medical Research

David Ofori-Adjei (Accra), Ph.D., University of Ghana

Speakers:

55. Management of severe malaria
Invited speaker: Bernhards Ogutu

56. Is pharmacovigilance regarding antimalarials in Africa an illusion?
Invited speaker: Ambrose Talisuna

57. Therapeutic efficacy of amodiaquine (AQ), sulfadoxinepyrimethamine( SP) and AQ+SP combination for treating uncomplicated malaria in Cameroon
Isabel Akaragwe

58. Efficacy of artemether/lumefantrine for the treatment of moderately severe malaria in children
Philip Sasi

59. Amodiaquine-artesunate versus artemether-lumefantrine: efficacy and safety for single or repeat episodes of uncomplicated malaria in Ghanaian children
Dr. George Obeng Adjei, Department of Child Health, Korle Bu Teaching Hospital, Accra, Ghana

60. HIV infection increases the risk of retreatment for uncomplicated malaria in Uganda
Dr. Anne Gasasira, Makerere University-University of California Malaria Collaboration

61. Albumin reduces the risk of death in children with severe malaria and acidosis in a Phase II randomised controlled trial of volume expansion
Dr. Kathryn Maitland, MIM Communications Network

---

Sign up for email alerts and stay informed about upcoming HealthCasts, and the latest health policy issues, news, and events.

• Consult our Frequently Asked Questions or How to View.
• Contact us by email with any comments, problems, suggestions.
• Call the kaisernetwork.org Help Desk at 202-347-5270.

Change Your Video Preferences